A PDF
A PDF
A PDF
This proposal is subject to our internal conflict and independence checks. This proposal is valid for a period of 60 days from the date of its
submission to you. The proposal will lapse unless the same is accepted by you within the specified time.
This material has been prepared by Deloitte Touche Tohmatsu India LLP (“DTTILLP”) on a specific request from you and contains
confidential information. The information contained in this material is intended solely for you thereby, any disclosure, copy or further
distribution of this material or the contents thereof is strictly prohibited.
This Proposal is intended solely for the information and internal use of Matrix Fine Sciences Pvt. Ltd.(MFSPL) and is not intended to be and
should not be used by any other person or entity. No other person or entity is entitled to rely, in any manner, or for any purpose, on this
Proposal.
2
©2019 Deloitte Touche Tohmatsu India LLP. 2
Our understanding
of your requirement
©2019 Deloitte Touche Tohmatsu India LLP. 3
Our
ACG is looking at defining RACI, DOA and process flows post
understanding
organisation restructuring, and align changes with existing systems
We understand that ACG Group (‘ACG’ Help review and define RACI (Responsible,
or ‘the Company’) has documented RACI accountable, consulted and informed) matrix across 4
process/procedure guidelines for group companies
business processes. Further, the
company has proactively identified need
to re-design the organization structure Help review and define DOA (Delegation of Authority)
DOA
where Deloitte has provided matrix at L4 level
recommendations for the corporate as
well as for its four companies viz. ACG
Engineering, ACG Associated Capsules
Recommend changes to align with existing system
Pvt. Ltd., ACG Pharmapack and ACG System alignment
applications post defining RACI and DOA
Inspection.
Deloitte’s proven credentials in developing RACI and DOA will ensure effective adoption across
organisation
©2019 Deloitte Touche Tohmatsu India LLP. ACG | Proposal for developing RACI and DOA 4
Scope and approach
1 2 3 4
Development of RACI and Post implementation
Development of DOA Alignment with system
Process flows review
• Understanding departments, • Understanding of departmental • Mapping RACI and DOA with • Post implementation reviews
process, current process owners structure, processes and sub existing systems • Identifying gaps
• Considerations till M-4 level processes till L-4 level • Alignment with SAP • Resolving issues for smooth
Key activities
Note: Timelines are subject to availability of process owners, key stakeholders and timely receipt of data
©2019 Deloitte Touche Tohmatsu India LLP. ACG | Proposal for developing RACI and DOA 6
Scope consideration Scope
We shall develop Process flows, RACI and DOA for following companies
Company Department
Corporate Finance (SSC)
SCM
ACG Group (Corporate) HR
IT
Marketing
Sales
Aftermarkets
New Product Development (NPD)
ACG Engineering Operations
Procurement
Logistics
Finance
Sales
Operations
ACG Associated Capsules Pvt. Ltd.
R&D
Finance
Sales
Aftermarkets
ACG Inspection NPD
Operations & SCM
Finance
©2019 Deloitte Touche Tohmatsu India LLP. ACG | Proposal for developing RACI and DOA 7
Phase 1: Development of RACI
RACI framework
Understanding KPIs
1
•Listing individual deliverables, activities or tasks
Understanding Teams
2
•Listing process owners, departments or individuals involved in undertaking tasks
Underlying Matrix
3
•Mapping individuals and tasks
Assigning Roles
4
•Identifying who is Responsible, Accountable, Consulted and Informed
©2019 Deloitte Touche Tohmatsu India LLP. ACG | Proposal for developing RACI and DOA 8
Phase 1: Development of RACI
Understanding RACI: Sample mapping for undertaking technology development task
©2019 Deloitte Touche Tohmatsu India LLP. ACG | Proposal for developing RACI and DOA 9
Phase 1: Development of process flows to relate RACI matrix
Understanding process: Sample process flow mapping for sales operations task
Illustrative & Non-exhaustive
Inside sales rep Sales admin Sales rep Sales manager VP Sales Inside sales mg Director
Customer Product
management quotations Sales
contract
Inventory Outsourcing
Material Outbound management
requirements control accounting
Price Bills
Invoice
management
©2019 Deloitte Touche Tohmatsu India LLP. ACG | Proposal for developing RACI and DOA 10
Phase 2: Development of DOA
DOA framework
Optimised DOA
Delegation DOA • To ensure necessary checks and balances are incorporated in the
characteristics system as automated/manual controls
©2019 Deloitte Touche Tohmatsu India LLP. ACG | Proposal for developing RACI and DOA 11
Phase 2: Development of DOA
Understanding DOA requirements across departments of an organisation
Inventory
Supply &
Support process
©2019 Deloitte Touche Tohmatsu India LLP. ACG | Proposal for developing RACI and DOA 12
Phase 2: Development of DOA
Scoping requirements across departments of an organisation
DOA preparation
©2019 Deloitte Touche Tohmatsu India LLP. ACG | Proposal for developing RACI and DOA 13
Phase 2: Development of DOA
Sample deliverables of DOA: Purchase department
Purchase Commercial
Purchase order / Service order Per PO – Upto INR Lacs Unit in charge
executive head
- Other materials Original or
- Services amended Purchase Commercial
Above INR Lacs Unit in charge President
executive head
Creation / Updation of new Purchase Commercial Plant accounts
Per creation As per policy
vendor master executive head head
PO issued against Annual rate Purchase Commercial
Per PO All values
contract executive head
Note:
• Vendor master creation to be done as per policy defined in procurement SOP
• Comparative statement approving authority will be same as PO approving authority
• Rate contract to be set up for all service level agreements which will include commercial head and representatives from production and accounts department as recommended by president
©2019 Deloitte Touche Tohmatsu India LLP. ACG | Proposal for developing RACI and DOA 14
Phase 3: Alignment with system
DOA, RACI integration with system
Identification of
Developing design
gaps and define Transport to
document as per
mapping in SAP production system
DOA configuration
system
DOA, RACI
Preparing test
Joint workshop
scrips to ensure Validation of DOA
with operations and
completeness enabled in SAP
technology team
(UAT)
Existing system configuration
Identifying manual,
existing systems Acceptance and go-
Logics Business signoff
and oppurtunities live enablement
to automate
©2019 Deloitte Touche Tohmatsu India LLP. ACG | Proposal for developing RACI and DOA 15
Phase 4: Post implementation review
Identifying issues and providing resolution
System Resolution
checks
Post implementation
review
©2019 Deloitte Touche Tohmatsu India LLP. ACG | Proposal for developing RACI and DOA 16
Team
Role Responsibilities
©2019 Deloitte Touche Tohmatsu India LLP. ACG | Proposal for developing RACI and DOA 18
Deloitte team
©2019 Deloitte Touche Tohmatsu India LLP. ACG | Proposal for developing RACI and DOA 19
Deloitte team
Bhumit is Manager with our Risk Advisory Pooja is a MBA/ M.com and Green Belt – Six
practice at Deloitte and has over all 6 plus years Sigma certified with over 13 years of experience
of experience in conducting risk based internal in Manufacturing and Pharmaceutical
audits, internal control reviews, process reviews operations. She has joined Deloitte in May 2017
and development of model business processes and has earlier worked with KPMG , DSM
for leading metal and mining, power, FMCG, Sinochem Pharmaceutical India Pvt. Ltd and
energy solutions and automotive clients. Cello International Pvt. Ltd. She has an
experience on wide range of engagements
Bhumit is leading a 5 member team at a
including risk based internal audits, process
polyester film manufacturing entity and a 3
audits, internal financial control and
member team at a global cement manufacturing
identification of significant process
entity for business process reviews.
improvement.
He has led 5 member team as a part of process
Pooja has led Process reviews at Large
review and process development assignment for
Multinational Pharmaceutical companies. Review
leading Aluminum manufacturing and Power
included areas such as Manufacturing
generating company for 2 years. He has also led
operations, Procure to Pay, Sales and
process reviews for Thermal power plant. He
Marketing, Order to Cash, Human Resources &
has efficiently managed review of core and
Payroll, International Supply Chain, Research
support functions within client timelines.
and Development review and Regulatory
He has exposure to ERP environment such as compliances.
SAP and fair knowledge of MM, FICO, PM & SD
She has also conducted Process framework
module consisting of operational transactions,
review for International subsidiaries of an Indian
report generation and analysis for various
Pharmaceutical (Multinational) organization in
process reviews across core functions.
countries -Japan, Philippines and South Africa.
©2019 Deloitte Touche Tohmatsu India LLP. ACG | Proposal for developing RACI and DOA 20
Deloitte team
Srinivas is a Deputy Manager in the Internal Varun has around 6 years of experience in
Audit team in Mumbai with over six years Internal audit, Risk based process reviews, Data
experience in delivering process reviews and Analytics and Internal Control Review. He works
internal audit services to several multinational with clients from Aluminium, Cement, Polyester
organizations. films, Oil and Cable manufacturing companies,
FMCG company and Power generation and
Srinivas has worked with two of the erstwhile
distribution company in India and Sri Lanka.
Big four professional services firms and catered
clients for varied services including internal Varun has handled Risk based process reviews /
audit, risk management, Internal Financial Internal Audit of core business processes like
Control (“IFC”) designing and testing. His key Sales and Marketing, Procurement w.r.t. Bulk
strengths include execution of Process Design materials, Service procurement, Inventory
and gap analysis, Operational Risk reviews, management, Production & Manufacturing,
review of process level controls. Treasury, Finance closure, Capex, Security
framework for manufacturing and power
Over the course of his professional career,
generation companies in India and Sri Lanka.
Srinivas has focused on delivering engagements
in the Pharmaceuticals, Life Sciences sector and Apart from core process reviews, special focus
Telecommunication. review such as review of MIS and Financials
including IFRS and IndAS financial statements,
Srinivas has led Process review of a domestic
review of Trial balance, Receivable management
Pharma client for its International Operations
and Payable management, conducting Physical
(B2B model) covering Product registration,
Verification (PV) and end to end quantity &
Pricing, Claims settlement and account
quality reconciliation of Bulk materials.
reconciliations.
©2019 Deloitte Touche Tohmatsu India LLP. ACG | Proposal for developing RACI and DOA 21
Credentials
ACG Associated Capsules Private Limited Bharat Serums and Vaccines Limited
Signet Chemical Corporation Private Limited Roche Products (India) Private Limited
Allergan Healthcare India Private Limited Carestream Health India Private Limited
Ordain Health Care Global Private Limited Meril Life Sciences Private Limited
RPG Life Sciences Limited Teva Pharmaceuticals & Chemicals Industries India Pvt Ltd
©2019 Deloitte Touche Tohmatsu India LLP. ACG | Proposal for developing RACI and DOA 23
Our illustrative credentials in Pharmaceuticals and Life Sciences
• Alkem Laboratories • Omron Healthcare India • Abbott India Limited • Abbott Healthcare • GE Healthcare Inc.
Limited Private Limited Private Limited
• Fulford India Limited • Merck & Company Inc
• Sentiss Pharmaceuticals • Otsuka Pharmaceutical • Abbott Laboratories
• Novartis India Limited • Novartis Healthcare
LLC India Private Limited
• Pfizer Inc Private Limited
• Sandoz AG
• Cadila Pharmaceuticals • Reliance GeneMedix
• Pfizer Limited • Wipro GE Healthcare
Ltd Limited • Wipro GE Healthcare
Private Limited
Private Limited • Sanofi India Limited
• Takeda Pharmaceutical • Kyowa Hakko Bio India
• Roche Molecular
Company Limited Private Limited • Sanofi India Limited • Johnson & Johnson
Systems Inc
Private Limited
• Sanofi India Limited • Novartis India Limited • Pfizer Inc
• Novartis AG
• Alere Medical Private
• Zydus Takeda • Sandoz Private Limited • Kulzer GmbH
Limited • Sanofi India Limited
Healthcare Pvt. Ltd.
• Abbott Healthcare
• MSD Pharmaceuticals
• Abbott Healthcare Private Limited
Private Limited
Private Limited
• India Medtronic
• Novartis International
• Johnson & Johnson Private Limited
AG
Private Limited
• Johnson & Johnson
• Medtronic Plc
• Pfizer Inc Private Limited
• Reliance Life Sciences
Private Limited
©2019 Deloitte Touche Tohmatsu India LLP. ACG | Proposal for developing RACI and DOA 24
Our Select advisory credentials for alignment recommendations of RACI / DOA in
ERP / systems
Sony Pictures
Networks India ATC Tires Pvt. Ltd. Tata Capitals L&T Finance Havmor Ice-Cream
Pvt. Ltd.
©2019 Deloitte Touche Tohmatsu India LLP. ACG | Proposal for developing RACI and DOA 25
Our
Our select SOP / DOA experience
credentials
Ground
handling Successfully provided diagnostics review of operating processes like revenue,
service planning and monitoring, support functions like finance and accounts, human
provider In resource and payroll
Mumbai
Real estate
agency Developed portfolio management services process manual
services
©2019 Deloitte Touche Tohmatsu India LLP. ACG | Proposal for developing RACI and DOA 26
Our
Our select SOP / DOA experience
credentials
©2019 Deloitte Touche Tohmatsu India LLP. ACG | Proposal for developing RACI and DOA 27
About Deloitte
REVENUE HEADCOUNT
US$43.2B 286,200
COUNTRIES AND
TERRITORIES
DELOITTE 150+
OFFICES
FY2018
725
SOCIETAL IMPACT
CONTRIBUTIONS
US$217M
DELOITTE PROFESSIONALS WHO
EXPERIENCED DELOITTE UNIVERSITY
77,3900
Deloitte member firms serve 82% of the 2017 fortune 500 companies
©2019 Deloitte Touche Tohmatsu India LLP. ACG | Proposal for developing RACI and DOA 29
Our value proposition Why Deloitte
We are one of the leading dedicated SOP development, internal audit and technology advisory practice and have invested heavily in
our people, tools and methodology to drive quality. We have delivered internal audit services to a wide range of complex
organizations in the pharmaceutical sector. Key to our approach is that for every client we tailor our approach to make the
partnership a success.
Understanding
your business
Strong National
Tools and and
Accelerators International
Presence
©2019 Deloitte Touche Tohmatsu India LLP. ACG | Proposal for developing RACI and DOA 30
Deloitte difference Why Deloitte
Understanding your business • Our understanding of the business enables us to obtain a deeper understanding of your
needs and serve you better
Experienced engagement team • Highly skilled team experienced in designing, documenting and implementing SOP for
firms with similar business functions with core Manufacturing, Pharmaceutical and
Life sciences
• Dedicated team for business division with their prior experience on providing solution
to industry/ sector
• Subject Matter Experts comprising Partners and Directors who are experts in the areas of
Manufacturing sector
Leading methodology and • We propose globally accepted methodology customized to the requirements of ACG
approach
• Our approach is focused at resolution of process related and interdepartmental issues
faced by the client
• We deploy globally tested tools and methodologies
• For specific subjects/ industries , we will ensure involvement of SME’s – GST, systems
etc.
Client centric focused • Partner-Led approach acting as Single Point of Contact (SPOC)
• Culture of “No-surprises” – Timely status updates
• Time commitment from Partner/ Director and Subject Matter Experts
Strong National and • Widespread global and national reach enables us to utilize team and resources from the
International Presence office nearest to the client location
• Shorter time-frame to mobilize resources due to widespread global and national reach
©2019 Deloitte Touche Tohmatsu India LLP. ACG | Proposal for developing RACI and DOA 31
About Deloitte About Deloitte
India clientele
(November 2018 BT500*)
New Delhi
11000+
Serves Serves
Jamshedpur
93 115
Ahmedaba Energy,
d Vadodara Consumer of of
Kolkata Professionals resources &
spread across 139 industrials 169
Mumbai Hyderab companies companies
Pune ad
Vijayawada
Goa
Bengaluru Serves Serves
Chennai 76 31
Kochi
Coimbatore Financial 4
of Life sciences &
healthcare
4
of
14
services
98 39
companies companies
Risk Advisory
*BT500 - Business Today publication about India’s top 500 performing companies
Consulting
©2019 Deloitte Touche Tohmatsu India LLP. ACG | Proposal for developing RACI and DOA 32
About Deloitte About Deloitte
SERVICES IN INDIA
• Strategic & • A Comprehensive • Global Business Tax • Corporate Finance & • Strategy and
Reputation Risk Audit Process Restructuring Operations
• Global Employer
• Regulatory Risk • Assurance Services Services • Forensic • Human Capital
• Financial Risk • Specialised Audit • Indirect Tax • M&A Transaction • Technology
Services Including Services
• Operational Risk • Mergers and • GUIDe (Government,
Detailed
Acquisitions (M&A) – • Valuation & Modelling Utilities,
• Cyber Risk Investigations
Tax Infrastructure and
Development)
• Transfer Pricing
• Business Process
Solutions
• Tax Analytics
Deloitte is well equipped to deliver solutions to the complex challenges faced by organisations across the public and private sectors. Being one of the
largest organisation, our edge lies in our ability to draw upon a well equipped globally customised services at a local office.
Note
All of the services listed here may not be available from every Deloitte member firm. In addition, there may be local regulations restricting the provision of certain services to
attest clients
©2019 Deloitte Touche Tohmatsu India LLP. ACG | Proposal for developing RACI and DOA 33
Deloitte refers to one or more of Deloitte Touche Tohmatsu Limited, a UK private company limited by guarantee (“DTTL”), its network of member firms, and their related divisions. DTTL and each of its member firms are
legally separate and independent divisions. DTTL (also referred to as “Deloitte Global”) does not provide services to clients. Please see www.deloitte.com/about for a more detailed description of DTTL and its member
firms.
This material has been prepared by Deloitte Touche Tohmatsu India LLP (“DTTILLP”), a member of Deloitte Touche Tohmatsu Limited, on a specific request from you and contains proprietary and confidential information.
This material may contain information sourced from publicly available information or other third party sources. DTTILLP does not independently verify any such sources and is not responsible for any loss whatsoever
caused due to reliance placed on information sourced from such sources. The information contained in this material is intended solely for you. Any disclosure, copying or further distribution of this material or its contents
is strictly prohibited.
Nothing in this material creates any contractual relationship between DTTILLP and you. Any mutually binding legal obligations or rights may only be created between you and DTTILLP upon execution of a legally binding
contract. By using this material and any information contained in it, the user accepts this entire notice and terms of use.
©2019 Deloitte Touche Tohmatsu India LLP. Member of Deloitte Touche Tohmatsu Limited
Deloitte Touche Tohmatsu India Private Limited (U74140MH199 5PTC093339), a private company limited by shares, was converted into Deloitte Touche Tohmatsu India LLP, a limited liability partnership (LLP
Identification No. AAE-8458),with effect from October 1, 2015.